Oncology Market Expected to Grow at 9.6% CAGR, Reaching USD 533.2 Bn by 2032 | DMR
GlobeNewswire
Insights, Projections, and Recent Developments in the Oncology Industry Highlighted in Latest Report
New York, April 24,..
Insights, Projections, and Recent Developments in the Oncology Industry Highlighted in Latest Report
New York, April 24,..
· Approval based on NETTER-P trial in which Lutathera demonstrated a consistent safety profile and comparable drug exposure..
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $VCYT--New Study Shows Veracyte’s Decipher Prostate Test is Prognostic for..